Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy

Fig. 3

Correlation between circulating serum cortisone in all patients on hydrocortisone replacement with; Bone formation markers (a) OC [1–49], (b) PINP, (c) Bone ALP and Bone resorption markers (d) CTX-I, (e) TRACP5b and (f) PINP: CTX ratio. OC [1–49] = osteocalcin; PINP = procollagen type 1 peptide; Bone ALP = bone alkaline phosphatase; CTX-I = C terminal cross-linking telopeptide; TRACP5b = tartrate resistant acid phosphatase 5b

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us